For some individuals, the risks of stopping abruptly may outweigh the potential risks of continuing
The medications are compounded in a 503(A) Compounding Pharmacy or 503(B) Outsourcing Facility
Risk of bias using Cochrane risk-of-bias tool for randomized trials-Deandfield, 2024
For a cash-pay patient, that translates to roughly $1,548/year on the Microdose tier, $2,148$2,748/year on Semaglutide Injection, and $2,748$3,708/year on Tirzepatide Injection well below FDA-approved branded GLP-1s at retail list price (~$1,000$1,350/month before insurance)
But the answer to whether tirzepatide will work for you specifically depends on why semaglutide did not work in the first place
Dopamine is critical to focus, motivation, and goal-setting